Oil And Oil Services

As we begin this new calendar year, the markets continue to surge into new highs even as some fatigue seems to be settling in among some individual issues.  Plotting the performance of select sectors versus the benchmark S&P shows that many of the strong momentum groups remain strong and not exhibiting conspicuous weakness. Technology stocks … Continue reading Oil And Oil Services

That Was Then, This Is Now Part 3

Part 3 of the Dow review MSFT Forecast:  "..$62.14 Microsoft was one of the steadiest performers of the Dow in 2016 with price action consistently showing a higher relative strength than the S&P. Despite the steady advance all year, the SCTR still remains high at 78 and looks very strong. The PNF chart shows a … Continue reading That Was Then, This Is Now Part 3

That Was Then, This Is Now Part 2

We continue with our Dow recap. XOM Forecast: "...$90.26 When viewed in the context of a longer term monthly chart, XOM is dead neutral essentially trading in a broad range for years. The SCTR reading is 43 which is just middling but XOM does perform a bit better than the S&P benchmark. There is a breakout … Continue reading That Was Then, This Is Now Part 2

The Trend Is Your Friend

The year 2017 was one of the most remarkable years in my investment history...or any one's investment history.  At the beginning of 2017, post the Trump election, the Dow index hovered at an already elevated level of 20,000.  It proceeded to advance another 5000 points to touch 25,000 by year's end; a 25% gain for … Continue reading The Trend Is Your Friend

Healthcare/Pharma Activity

In mid June of this year, we pointed out some activity that appeared interesting from the longer term chart patterns of some healthcare/pharma stocks.  One of the stellar performers since then has been Abbvie (ABBV), a pharma company which produces Humira, a top selling anti inflammatory treatment among other high profile drug therapies.  After breaking … Continue reading Healthcare/Pharma Activity